83 related articles for article (PubMed ID: 1806185)
1. [IL 6 and lymphoproliferative diseases].
Lévy Y; Brouet JC
C R Seances Soc Biol Fil; 1991; 185(5):262-7. PubMed ID: 1806185
[TBL] [Abstract][Full Text] [Related]
2. IL6 and lymphoproliferative disorders.
Brouet JC; Levy Y
Nouv Rev Fr Hematol (1978); 1991; 33(6):433-6. PubMed ID: 1818294
[TBL] [Abstract][Full Text] [Related]
3. [Interleukin 6 and lymphoplasmocytic proliferation].
Brouet JC; Lévy Y
Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):225-6. PubMed ID: 8337132
[No Abstract] [Full Text] [Related]
4. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.
Westendorf JJ; Ahmann GJ; Armitage RJ; Spriggs MK; Lust JA; Greipp PR; Katzmann JA; Jelinek DF
J Immunol; 1994 Jan; 152(1):117-28. PubMed ID: 7504707
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines.
Levy Y; Tsapis A; Brouet JC
J Clin Invest; 1991 Aug; 88(2):696-9. PubMed ID: 1864979
[TBL] [Abstract][Full Text] [Related]
6. Regulation of interleukin 6 in multiple myeloma and bone marrow stromal cells.
Chauhan D; Uchiyama H; Urashima M; Yamamoto K; Anderson KC
Stem Cells; 1995 Aug; 13 Suppl 2():35-9. PubMed ID: 8520509
[TBL] [Abstract][Full Text] [Related]
7. [Growth characteristics of a human myeloma cell line transfected with IL-6 cDNA].
Takahashi T; Okuno Y; Ohsugi Y
Rinsho Ketsueki; 1993 Apr; 34(4):423-6. PubMed ID: 8510328
[TBL] [Abstract][Full Text] [Related]
8. Delineation of the roles of paracrine and autocrine interleukin-6 (IL-6) in myeloma cell lines in survival versus cell cycle. A possible model for the cooperation of myeloma cell growth factors.
Jourdan M; Mahtouk K; Veyrune JL; Couderc G; Fiol G; Redal N; Duperray C; De Vos J; Klein B
Eur Cytokine Netw; 2005; 16(1):57-64. PubMed ID: 15809207
[TBL] [Abstract][Full Text] [Related]
9. [B lymphoproliferative syndrome with characteristics common to chronic lymphatic leukemia, Waldenström disease and plasmacytic leukemia].
Tosato F; Fossaluzza V; Sala P; Tonutti E
Minerva Med; 1984 Nov; 75(44):2691-4. PubMed ID: 6440066
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma.
Klein B; Zhang XG; Jourdan M; Boiron JM; Portier M; Lu ZY; Wijdenes J; Brochier J; Bataille R
Eur Cytokine Netw; 1990; 1(4):193-201. PubMed ID: 2104241
[TBL] [Abstract][Full Text] [Related]
11. [Pulmonary lymphoproliferative syndromes].
Redón J; Perpiñá M; Abad F; Herranz C; Caballero M; Marco V
Rev Clin Esp; 1982 Jan; 164(2):75-82. PubMed ID: 6806872
[No Abstract] [Full Text] [Related]
12. [Biology of interleukin-6. Role in lymphoplasmacytic hemopathies].
Levy Y; Brouet JC
Ann Med Interne (Paris); 1992; 143(8):533-43. PubMed ID: 1303597
[No Abstract] [Full Text] [Related]
13. Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines.
Beatty PR; Krams SM; Martinez OM
J Immunol; 1997 May; 158(9):4045-51. PubMed ID: 9126962
[TBL] [Abstract][Full Text] [Related]
14. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
Westendorf JJ; Jelinek DF
J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
[TBL] [Abstract][Full Text] [Related]
15. Enforced expression of superoxide dismutase 2/manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasone-induced apoptosis.
Hodge DR; Xiao W; Peng B; Cherry JC; Munroe DJ; Farrar WL
Cancer Res; 2005 Jul; 65(14):6255-63. PubMed ID: 16024627
[TBL] [Abstract][Full Text] [Related]
16. Role of INTERLEUKIN-6 in the pathogenesis of multiple myeloma.
Gadó K; Domján G; Hegyesi H; Falus A
Cell Biol Int; 2000; 24(4):195-209. PubMed ID: 10816321
[TBL] [Abstract][Full Text] [Related]
17. [Cytokines and lymphoplasmocytic proliferations: essential role of interleukin 6].
Bataille R; Klein B
Rev Prat; 1993 Feb; 43(3):275-8. PubMed ID: 8502954
[TBL] [Abstract][Full Text] [Related]
18. [Signal transduction and biological function of IL-6 in a human myeloma cell line-XG-7].
Song L; Shen B
Zhonghua Yi Xue Za Zhi; 2000 Nov; 80(11):845-8. PubMed ID: 11218881
[TBL] [Abstract][Full Text] [Related]
19. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis in Waldenstrom's macroglobulinemia.
Rajkumar SV; Hayman S; Greipp PR
Semin Oncol; 2003 Apr; 30(2):262-4. PubMed ID: 12720149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
